Topic:

Social Media

Latest Headlines

Latest Headlines

Big Pharma sees danger, not safety, in FDA's new social media guidance

The FDA may have released its latest social media guidance in January, but judging by the industry's reaction, it appears some of pharma's marketers don't have any more answers than they did before. In fact, they have more questions.

Pfizer, PhRMA and others pick holes in FDA social media guidance

Drugmakers received the first slice of FDA social media guidance in January, and now the FDA's mailbag is filling up with letters on First Amendment protections, "jurisdictional creep" and other topics from the likes of Pfizer and PhRMA.

Sanofi beefs up social media channels with Spanish Twitter push

Sanofi has added a new Twitter handle to its Iberian lineup, @Sanofifarmacia, designed to create a pool of reference information and help community pharmacies in Spain promote their businesses.

Pharma continues to grapple with trial participants' use of social media

While it is years now since clinical trial participants started talking about their experiences online, the industry is still searching for the best way to approach the phenomenon. And with pharma needing to improve the clinical trial process, the onus is on the industry to find systems that not only manage the negative implications of social media, but tap into its power, too.

Soon after media storm fades, Chimerix CEO Moch is out the door

Just weeks after enduring a storm of controversy triggered by his initial refusal to provide a potent but experimental antiviral to a dying child under a compassionate use program, Chimerix CEO Ken Moch is out. The company announced that Moch had resigned--completely unexpectedly--to "pursue other interests" as the board introduced a new CEO to run the company.

Tufts survey shows social media still on fringes of clinical trials

It is almost four years since Facebook passed 500 million users. And while the role of it and other social media in clinical trials has generated lots of media coverage and conference chatter, the industry is yet to fully embrace the tools. Survey data published this week show just how there is to go.

Eli Lilly begins sharing photos on Instagram

The account--elilillyco--has posted old photographs of Lilly's facilities and researchers alongside pictures of what its current staff are doing.

Report: Big Data, social media and mobile double their share of biopharma marketing mix

Over the past decade a plethora of digital formats have begun competing with print, television, radio and conferences for biopharma marketeers' budgets. And while initial uptake was slow, a survey has now found Big Data, social media and mobile have doubled their share of the marketing mix since 2012.

Pfizer CEO begins contributing to LinkedIn's publishing platform

Pfizer CEO Ian Read has become the first pharma executive to contribute an article to LinkedIn's publishing platform.

China cracks down on 'false' bird flu rumors on social media

Chinese police have detained a man for allegedly spreading false bird flu rumors on social media, Reuters reports.